Companies: 10,795·Total market cap: $144.5T
Algernon Pharmaceuticals Inc.

Algernon Pharmaceuticals Inc.

AGN.CNCNQHealthcare
$0.05
+$0.00(+0.00%)
Market Cap$157523
P/E Ratio—
52W High$1
52W Low$0.045
PE RatioMarket CapForecast

Algernon Pharmaceuticals Inc. (AGN.CN) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

agn.cn · pe ratio · data through Jun 10, 2026

Core PE Ratio Metrics

Trailing 12 months · TTM

Insufficient PE history data (fewer than 3 valid fiscal years).

PE Ratio vs Peers

Biotechnology · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Algernon Pharmaceuticals Inc.
Algernon Pharmaceuticals Inc.You
AGN.CN
$0MN/A——
Appili Therapeutics Inc.
Appili Therapeutics Inc.
APLI.TO
$2MN/A—-$0.02
City View Green Holdings Inc.
City View Green Holdings Inc.
CVGR.CN
$1MN/A—-$0.02
Entheon Biomedical Corp.
Entheon Biomedical Corp.
ENBI.CN
$1MN/A—-$0.02
Restart Life Sciences Corp.
Restart Life Sciences Corp.
HEAL.CN
$3MN/A—-$0.04
Universal Ibogaine Inc.
Universal Ibogaine Inc.
IBO.V
$2MN/A—-$0.06
Lifeist Wellness Inc.
Lifeist Wellness Inc.
LFST.V
$2MN/A—-$0.08

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Algernon Pharmaceuticals Inc. (AGN.CN) measures how much investors pay for each dollar of the company's trailing earnings. AGN.CN's current PE ratio of N/A is calculated by dividing its stock price of $0.04 by its TTM earnings per share of —.

PE Ratio = Stock Price ÷ EPS (TTM)
= $0.04 ÷ — = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.
Price historyFinancial statementsEarnings

Frequently asked questions

AGN.CN pe ratio · 6 questions

AGN.CN's current PE ratio is N/A as of 2026-06-10, based on a stock price of $0.04 and TTM EPS of —. Data sourced from Financial Modeling Prep via AGN.CN's SEC 10-K and 10-Q filings.

AGN.CN PE ratioWhat is AGN.CN PE ratioCurrent PE ratio of AGN.CNAGN.CN PE ratio today

▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Algernon Pharmaceuticals Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-10